Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | -0.69% | +9.09% | -46.67% |
Chart calendar Enlivex Therapeutics Ltd.
Upcoming events on Enlivex Therapeutics Ltd.
Past events on Enlivex Therapeutics Ltd.
2024-04-12 08:30 am | Allocetra Phase II Trial Results Call |
2024-03-20 | RedChip Investor Group Call |
2023-09-12 05:00 pm | H.C. Wainwright Global Investment Conference |
2023-06-26 08:00 am | Q1 2023 Earnings Release |
2023-06-09 11:30 am | Jefferies Global Healthcare Conference |
2023-06-01 12:00 pm | International Society for Cell & Gene Therapy Meeting - Poster No:1057 |
2023-06-01 12:00 pm | International Society for Cell & Gene Therapy Meeting - Poster No:1003 |
2023-05-31 01:00 pm | International Society for Cell & Gene Therapy Meeting - Poster No:805 |
2022-12-05 08:00 am | Q3 2022 Earnings Release |
2022-11-09 | Society for Immunotherapy of Cancer Meeting |
2022-10-06 02:30 pm | Macrophage directed Therapies Summit |
2022-09-15 09:20 am | Cantor Cell and Genetic Medicines Conference - Panel |
2022-09-14 03:10 pm | Baird Global Healthcare Conference |
2022-09-13 11:00 am | H.C. Wainwright Global Investment Conference |
2022-09-11 | European Society for Medical Oncology |
2022-08-22 08:00 am | Interim 2022 Earnings Release |
2022-06-09 01:00 pm | Jefferies Healthcare Conference |
2022-06-05 09:00 am | American Society of Clinical Oncology Meeting |
2022-05-22 | H.C. Wainwright Global Investment Conference - Pre-Recorded |
2022-04-29 08:41 am | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -8,62 -8,08 -6.67% | -9,79 -8,79 -11.35% | -19,3 -17,0 -13.73% | -25,8 -24,0 -7.7% | -29,4 -23,8 -23.72% | -16,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -14,5 -15,6 7.04% | -31,1 -30,9 -0.61% | -29,1 -25,2 -15.47% | -16,3 |
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -14,5 -15,6 7.04% | -31,1 -30,9 -0.61% | -29,1 -25,2 -15.47% | -16,3 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -0,81 -0,86 5.81% | -1,69 -1,68 -0.6% | -1,56 -1,36 -14.71% | -0,86 |
Announcement Date | 30/04/20 | 30/04/21 | 29/04/22 | 31/03/23 | 29/03/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million USD | Released Forecast Spread | -7,81 -4,85 -61.11% | -6,40 -8,10 20.94% | -5,87 -7,70 23.75% | -5,68 -5,30 -7.11% | -7,85 -6,00 -30.75% | -6,78 -7,30 7.08% | -6,65 -7,00 5.01% | -5,63 -6,00 6.2% | -10,3 -4,70 -119.89% | -4,60 | -4,40 | -3,80 | -3,50 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,74 -5,31 10.81% | -8,23 -7,59 -8.44% | -9,91 -8,20 -20.89% | -5,73 -5,31 -8.05% | -7,19 -7,00 -2.7% | -7,22 -7,31 1.19% | -6,79 -8,00 15.1% | -5,96 -6,01 0.72% | -9,10 -5,20 -74.9% | -4,60 | -4,40 | -3,80 | -3,50 | |
Net income Million USD | Released Forecast Spread | -4,74 -5,31 10.81% | -8,23 -7,59 -8.44% | -9,91 -8,20 -20.89% | -5,73 -5,31 -8.05% | -7,19 -7,00 -2.7% | -7,22 -7,31 1.19% | -6,79 -8,00 15.1% | -5,96 -6,01 0.72% | -9,10 -5,20 -74.9% | -4,60 | -4,40 | -3,80 | -3,50 | |
EPS USD | Released Forecast Spread | -0,26 -0,28 7.14% | -0,45 -0,41 -9.76% | -0,54 -0,45 -20% | -0,31 -0,29 -6.9% | -0,39 -0,38 -2.63% | -0,39 -0,40 2.5% | -0,37 -0,43 13.95% | -0,32 -0,32 0% | -0,48 -0,28 -71.43% | -0,25 | -0,24 | -0,20 | -0,17 | -0,14 |
Announcement Date | 29/04/22 | 27/05/22 | 22/08/22 | 02/12/22 | 31/03/23 | 16/06/23 | 01/09/23 | 09/11/23 | 29/03/24 | - | - | - | - | - |
Past sector events for Enlivex Therapeutics Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENLV Stock
- Calendar Enlivex Therapeutics Ltd.